Results 181 to 190 of about 16,933 (236)

Microbial metabolite-driven mechanisms linking the gut microbiome to atherosclerosis: multi-omic and translational perspectives. [PDF]

Gut Microbes
Masiá M, Gutiérrez F.
europepmc   +1 more source

Gut microbiota-derived metabolites in cardiovascular disease: mechanisms, disease-specific roles, and translational opportunities. [PDF]

Front Cardiovasc Med
Zhu G, Man J.
europepmc   +1 more source

Gut microbe-generated metabolite trimethylamine N-oxide and risk of abdominal aortic aneurysm: a cohort study. [PDF]

Eur Heart J
Li XS, Wang M, Wang Z, Fan B, Tian MY, Filippazzo J, Lee Y, Mallela DP, Mao K, Liu Y, Lemaitre RN, Xie V, Diaz E, DiDonato JA, Tang WHW, de Oliveira Otto MC, Budoff MJ, Owens AP, Newman AB, Cameron SJ, Siscovick DS, Lusis AJ, Mozaffarian D, Hazen SL.   +23 more
europepmc   +1 more source

Gut Dysbiosis, Uremic Toxins, and NLRP3 Signaling in Chronic Kidney Disease: From Mechanistic Evidence to Clinical Biomarker Evaluation. [PDF]

Diagnostics (Basel)
Donath-Miklos I, Știrbu O, Popețiu RO, Crișan AS, Vulciu PA, Coman RA, Avram CR, Roman DR, Bugari RA, Zdremțan D, Orodan M, Pilat L, Rus LA, Firu CG, Roșu MC, Borta SM.   +15 more
europepmc   +1 more source

Gut Dysbiosis, Sex, and Vascular Smooth Muscle Cells in Abdominal Aortic Aneurysms. [PDF]

Curr Atheroscler Rep
Hatcher G, Kazaleh M, Patil R, Ailawadi G, Salmon M.   +4 more
europepmc   +1 more source

Elevated plasma TMAO levels associated with all-cause mortality in CAD patients in South China. [PDF]

BMC Cardiovasc Disord
Zhang H, Peng YY, Lu XY, Li YX, Li WZ, Hu Y, Wan L, Chen BL.   +7 more
europepmc   +1 more source

Gut metabolites: key factors in the cross-talk between the gut microbiota and tumor immunotherapy. [PDF]

Front Immunol
Zeng L, Ren Y, Huang H, Wang Q, Li H, Song J, He F, Li J.   +7 more
europepmc   +1 more source